Development and pilot investigation of behavioral activation for negative symptoms

Hilary Mairs; Karina Lovell; Malcolm Campbell; Philip Keeley

doi:10.1177/0145445511411706

Development and pilot investigation of behavioral activation for negative symptoms

Hilary Mairs, Karina Lovell, Malcolm Campbell, Philip Keeley

Research output: Contribution to journal › Article › peer-review

Abstract

Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment. © The Author(s) 2011.

Original language	English
Pages (from-to)	486-506
Number of pages	20
Journal	Behavior Modification
Volume	35
Issue number	5
DOIs	https://doi.org/10.1177/0145445511411706
Publication status	Published - Sept 2011

Keywords

negative symptoms
psychosis
psychosocial treatment
schizophrenia

Access to Document

10.1177/0145445511411706

Cite this

@article{aae6fb6019ad4ef5981721c69bbfe582,

title = "Development and pilot investigation of behavioral activation for negative symptoms",

abstract = "Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment. {\textcopyright} The Author(s) 2011.",

keywords = "negative symptoms, psychosis, psychosocial treatment, schizophrenia",

author = "Hilary Mairs and Karina Lovell and Malcolm Campbell and Philip Keeley",

year = "2011",

month = sep,

doi = "10.1177/0145445511411706",

language = "English",

volume = "35",

pages = "486--506",

journal = "Behavior Modification",

issn = "0145-4455",

publisher = "SAGE Publications Inc.",

number = "5",

}

TY - JOUR

T1 - Development and pilot investigation of behavioral activation for negative symptoms

AU - Mairs, Hilary

AU - Lovell, Karina

AU - Campbell, Malcolm

AU - Keeley, Philip

PY - 2011/9

Y1 - 2011/9

N2 - Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment. © The Author(s) 2011.

AB - Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment. © The Author(s) 2011.

KW - negative symptoms

KW - psychosis

KW - psychosocial treatment

KW - schizophrenia

U2 - 10.1177/0145445511411706

DO - 10.1177/0145445511411706

M3 - Article

SN - 0145-4455

VL - 35

SP - 486

EP - 506

JO - Behavior Modification

JF - Behavior Modification

IS - 5

ER -

Development and pilot investigation of behavioral activation for negative symptoms

Abstract

Keywords

Access to Document

Fingerprint

Cite this